DENTOALVEOLAR SURGERY
COMPLICATION RATE OF OSTEOCONDUCTIVE MEMBRANES OVER FRESH ALVEOLAR SOCKETS
Irina Pohodenko-Chudakova 1a , Tamara Tserkhava 2b * , Katsiaryna Maksimovich 1c , Yury Zenkevich 2d
1
Department of Oral Surgery , Dental Faculty , Belarusian State Medical University , Minsk , Republic of Belarus
2
Department of Pediatric Dentistry , Dental Faculty , Belarusian State Medical University , Minsk , Republic of Belarus a
MSD , PhD , Professor , Head b
MSD , PhD , Professor , Head c
DMD , Medical Science Doctoral Student , Assistant d
DMD , Assistant
Academic Editor : Gavriel Chaushu , DMD , MSc , Professor , Tel Aviv University , Tel Aviv , Israel
Received : July 16 , 2017
Revised : July 29 , 2017 Accepted : August 29 , 2017 Published : August 30 , 2017
Cite this article : Pohodenko-Chudakova I , Tserakhava T , Maksimovich K , Zenkevich Y . Complication rate of osteoconductive membranes over fresh alveolar sockets . Stoma Edu J . 2017 ; 4 ( 3 ): 171-174 .
Abstract
DOI : 10.25241 / stomaeduj . 2017.4 ( 3 ). art . 2
Introduction : The aim of the study was to assess the clinical efficacy of the osteoconductive bioresorbable membranes “ Collapan ” and “ Collost ” used for the preservation of the alveolar process and to compare it with the natural bone healing of an alveolar socket . Materials and methods : The 67 patients observed were divided into 3 groups . The first group included 20 individuals who were treated by covering the alveolus with the “ Collapan ” membrane . Group 2 included 22 patients in whom the “ Collost ” membrane was used . The third group ( control ) consisted of 25 patients in whom the alveolus was not covered with any membrane over the natural blood clot . The clinical efficacy of the membranes was based on the number of complications in the postoperative period . Also , the level of alveolar bone reduction was measured using residual height and width as parameters . Results : In the postoperative period , 6 ( 9 %) complications of an infectious-inflammatory nature were detected in group 1 , 2 ( 3 %) - in group 2 , 19 ( 28 %) - in group 3 . The use of the “ Collost ” yielded the best result in preserving alveolar height and width . Conclusion : The results of this pilot study showed that it is appropriate to use the osteoplastic bioresorbable “ Collost ” and “ Collapan ” membranes due to the low incidence of complications and the favourable effect on preserving bone volume . Keywords : dentoalveolar surgery , alveolar socket preservation , osteoconductive membranes .
Original Articles
1 . Introduction Preservation of bone volume after tooth loss increases quality of life 1 and allows multiple choices of dental rehabilitation after tooth loss . 2 Loss of alveolar bone volume after tooth extraction remains a challenge in oral surgery , 3 both after tooth extraction and after loss of jaw bone due to tumor lesions in the jaw . 4 The width of the alveolar ridge decreases in range from 25 % to 50 % during the first year , which is 5-7 mm , even in case of absence of complications after tooth extraction . It should be emphasized that 2 / 3 of the loss of the alveolar bone volume occurs during the first three months after tooth extraction . In the same period , there is a significant loss of bone volume in the vertical direction , which , as a rule , is 0.9-3.25 mm . 3 Even removal of the third lower molar can lead to jaw bone loss , 5 even in patients aged 15-35 years . 6 Further , surgical manipulation and multiple curettage of alveolitis sicca could contribute to the progression of alveolar bone atrophy . Bone loss at an age between 15-35 years also bears social and economic significance . 7 , 8 The aim of the study was to assess the clinical efficacy of the osteoconductive bioresorbable “ Collapan ” and “ Collost ” membranes used to minimize bone loss in the alveolar sockets in the lower jaw after tooth extraction and to compare it with the bone wound healing “ under the blood clot ”. There were 67 patients ( men ) under observation , aged 15 to 70 who were divided into 3 groups . All the patients signed the informed agreement for participation in the study , which was approved by the commission on bioethics of the Belarusian State Medical University . The first group included 20 individuals in whom the “ Collapan ” membrane ( Intermedapatit Ltd , Moscow , Russia ) was used . Collapan is a biocomposite , consisting of synthetic hydroxyapatite , collagen and antimicrobial agent ( lincomycin hydrochloride ,
* Corresponding author : Professor Tamara Tserakhava , MsD , PhD , Head of the Pediatric Dentistry Department , Dental Faculty , Belarusian State Medical University , 74-81 , Dzerzhinski Ave ., BY-220116 Minsk , Republic of Belarus Tel : + 375 17 272-61-96 , Fax : + 375 17 272-61-97 , e-mail : tsetam @ mail . ru
Stomatology Edu Journal
171